A complete guide to clinical research in UK general practice — what it is, who funds it, how it's regulated, and why it matters.
Primary care research is clinical research conducted in or through primary care settings — principally GP practices, but also community pharmacies, dental practices, and other first-contact healthcare providers. It encompasses the full range of research methodologies: randomised controlled trials, observational studies, real-world evidence studies, service evaluations, and quality improvement initiatives.
In the UK, primary care is usually the first point of contact for patients with the NHS. GPs and their teams manage over 80% of NHS consultations and hold longitudinal health records for registered patients spanning decades. This makes primary care uniquely powerful as a research setting.
The case for primary care research is compelling and underappreciated. Most clinical research has historically been conducted in hospitals — but hospitals see a skewed, acutely ill population. Primary care sees everyone: the well, the worried well, the chronically ill, the young, the elderly, and the socially deprived communities that are most often underrepresented in clinical trials.
Common conditions — diabetes, hypertension, respiratory disease, depression, wound care, women's health — are managed almost entirely in primary care. Research conducted in GP settings on these conditions is more generalisable, more representative, and more directly applicable to real-world clinical practice than equivalent hospital-based research.
Sponsored by pharmaceutical or medical device companies, commercial trials test investigational products in GP populations. Primary care is particularly well suited to Phase III and IV trials of products for common, community-managed conditions. These trials generate income for practices and direct patient benefit through earlier access to new treatments.
Studies adopted onto the NIHR research portfolio are eligible for service support costs from the NHS. These cover a wide range of academic and commercially co-funded studies across all therapeutic areas.
Observational studies using GP electronic health records (EHR) to understand how treatments perform in real clinical practice. Primary care EHR data from EMIS and SystmOne systems is among the richest longitudinal clinical data available anywhere in the world.
Evaluations of existing or new services within their normal care pathway. Critically, service evaluations do not require Research Ethics Committee (REC) approval, allowing rapid setup — often within two weeks. They are ideal for device evaluations, new service pathways, and in-service assessments of pharmaceutical products.
Initiatives to improve care processes or outcomes within a practice or network. QI studies also do not require REC approval and can be completed rapidly across multiple sites.
The main funders of primary care research in the UK are the National Institute for Health and Care Research (NIHR), which provides infrastructure funding, service support costs, and direct research grants; the pharmaceutical and medical device industry, which funds commercial trials; research charities; and academic institutions, often in collaboration with the above.
NIHR has recently launched new Strategic Funding and Wider Care Settings Funding streams specifically to build primary care research infrastructure across England.
Patients in research-active practices benefit from earlier access to new treatments, more frequent clinical monitoring, involvement in science that shapes future care, and the knowledge that their participation contributes to better outcomes for future patients. Research practices consistently report higher patient satisfaction and engagement than non-research practices.
Read our step-by-step guide: How to Set Up a GP Clinical Trial Site →
Or talk to PCRA about joining the network: pcralliance.uk/contact →
The Primary Care Research Alliance delivers commercial and NIHR research across 30+ GP practices.
Talk to PCRA →